BioNano Elects David Barker, Ph.D., Former Chief Scientific Officer of Illumina, as Chairman of the Board
Further Strengthens Leadership Team with Two Executive Appointments
SAN DIEGO, CA – BioNano Genomics, the leader in physical genome mapping, today announced that it has elected David Barker, Ph.D., former Chief Scientific Officer of Illumina, as Chairman of the Board. BioNano has further strengthened its executive management team with two additional appointments: Sean Paolino to Vice President, Finance and Warren Robinson to Vice President, Global Sales and Marketing.
David Barker, Ph.D., commented, “The Irys® next-generation mapping (NGM) system from BioNano systematically and comprehensively detects large structural variations in the genome. These variations
have the potential to revolutionize how we understand genome biology and its role in human disease.
While I’ve served on the Board of BioNano for several years, I’m honored to now lead the Board as the
Company navigates a strategic path forward in its next phase of commercial growth and development.”
“The

